Sage Journals: Discover world-class research

Abstract

Nephrolithiasis is a prevalent condition characterized by the formation of urinary tract stones, with a high incidence rate worldwide. The recurrent nature of this disease often directs the public to seek alternative therapies, including herbal medicine, due to a common perception of its safety. However, emerging evidence emphasizes the potential for herb–drug interactions, which may pose serious risks to patient health, particularly among elderly individuals and those with chronic diseases. In light of the increasing use of herbal remedies worldwide, this review aims to investigate the potential interactions between conventional drugs and commonly used antiurolithiatic medicinal plants, based on findings from a recent ethnobotanical survey. Seven frequently used medicinal plants in Iraq were identified and reviewed, utilizing data published between 1900 and 2025, with a particular focus on pharmacokinetic and pharmacodynamic interaction mechanisms. This review intends to help healthcare professionals identify and manage potential herb–drug interactions, thereby enhancing patient safety and informed clinical decision-making in nephrolithiasis management.

Keywords

Nephrolithiasis kidney stone herbal medicine herbal-drug interaction Iraqi herbalists

Introduction

Nephrolithiasis, also known as kidney stone disease, is a common condition worldwide characterized by the formation of crystalline stones of varying composition within the urinary tract.¹ It is associated with a high incidence and recurrence rate in various regions of the globe^,² as well as in the Africo-Asian region known as the stone-forming belt.³ Iraq, as geographically positioned in this area, demonstrates a significant proportion of kidney stone disease among all patients with urologic conditions.^4,5 The recurrent nature of kidney stone disease directs patients to explore alternative herbal therapies arising from their belief in the safety of these products.⁶ However, accumulating evidence suggests that the concurrent use of herbal remedies and conventional medications may result in clinically significant herb–drug interactions, particularly in elderly patients and those exposed to polypharmacy, where the use of multiple drugs increases the risk of adverse interactions.^7,8 In Iraq, the use of medicinal plants for nephrolithiasis management remains common.⁹ A recent Scopus-indexed cross-sectional survey conducted in 2024 among Iraqi herbalists identified seven widely used medicinal plants that are frequently administered alongside conventional pharmacotherapy.¹⁰ Despite their extensive use, systematic evaluations of potential herb–drug interactions involving these plants remain limited.

Therefore, this study aims to address this gap by examining available pharmacological, phytochemical, and clinical evidence related to potential drug–herbal interactions, to support healthcare professionals in improving patient safety and preventing adverse outcomes in nephrolithiasis management.

Review Methodology

This mini-review was designed to examine the herbal-drug interactions of commonly used medicinal herbs in managing kidney stones in Iraq, using relevant scientific data extracted from various sources, including PubMed, Web of Science, HerbMed, NatMed Pro (formerly Natural Medicines), UpToDate Lexidrug, Medline, and Embase. Different articles and studies were reviewed for the last 20 years and extended later than 2000 in some cases to gather relevant data due to the minimal studies available in this area; the search involved using the scientific names of the selected herbs in addition to keywords such as “drug-herbal interaction,” “adverse effects,” “safety,” “toxicity,” “pharmacokinetic, pharmacodynamic interactions”. The inclusion criteria were all studies and reviews, including in vivo and in vitro studies, as well as case reports. only English-based articles were included. Studies were selected based on their most recent publication and screened for their titles, abstracts, and full texts to obtain the necessary data. The tables demonstrating interactions were arranged and designed according to the NatMed Pro database stop light rating system, which is explained in Figures 1 and Table 1. This shows the occurrence/severity rating and explanations, in addition to the level of evidence used, respectively.

Figure 1.

Stop light rating system adapted from the NatMed Pro database.

Table 1.

Level of Evidence and Definitions Adapted from the NatMed Pro Database.

Level Letter	Definition
Level A	High-quality randomized controlled trial (RCT) High-quality meta-analysis (quantitative systematic review)
Level B	Nonrandomized clinical trial Nonquantitative systematic review Lower quality RCT Clinical cohort study Case-control study Historical control Epidemiologic study
Level C	Consensus Expert opinion
Level D	Anecdotal evidence In vitro or animal study Theoretical, based on pharmacology

Evidence Synthesis

This study gathered data on the general information of the seven selected herbs, focusing on their potential drug-herbal interactions through a thorough review of a large number of articles across various resources. Results are represented in detail in Tables 1 to 7.

Adiantum capillus-veneris

The first plant in this review is Adiantum capillus-veneris (A. capillus-veneris) of the Adiantiaceae, commonly named Maidenhair fern. This herb is traditionally used in the management of respiratory disorders such as cold, asthma, cough, and pneumonia,^11,12 Several studies examined its pharmacological effects as an antioxidant, anti-inflammatory, antidiabetic, antibacterial anti cancer, antidiarrheal, and antispasmodic^13–16; in addition to its role in hypothyroidism, and activity against testosterone-induced alopecia.^17,18 It acts as a lithiasis agent in the treatment of kidney stones, as demonstrated by several studies, and inhibits crystal aggregation, particularly of calcium crystals.^19–21 The phytochemical constituents responsible for the medicinal use of this plant appear to be more than 130 chemicals related to different chemical classes, namely triterpenoids, phyto steroids, flavonoids (quercetin, kaempferol, rutin and gallic acid), phenyl propanoids, and other phenolic compounds, such as coumarins, carotenoids, in addition to fatty acids, mucilage, and minerals.^11,17

Regarding the plant's safety, limited studies have been conducted on the adverse effects and toxicity. In the evaluation of the acute toxicity in animals, mice administered A. capillus-veneris extract at doses up to 2 g/kg body weight exhibited no signs of mortality or apparent behavioral abnormalities, even at this elevated dose¹⁷; however, this plant is contraindicated in pregnancy due to its anti- implantation property²²; and additional toxicological studies are still needed to certain their safety in humans.^17,22

Drug-herbal interactions for this plant have not been investigated; despite extensive searching of all databases, the author reported theoretical interactions based on the plant's pharmacological activities derived from some studies, which are presented in “Table 2”; with monitoring tips presented in Figure 2.

Figure 2.

Drug-herbal interaction of Adiantum capillus-vene and monitoring tips (created using BioRender).

Table 2.

The Theoretical Drug-Herbal Interactions of Adiantum capillus-veneris.

Conventional Medications	Interaction mechanism	Outcome	Interact rating	Occurrence	Severity	Level of evidence	Ref.
Antihyperlipidemic medication	Decrease LDL, VLDL, TC Pharmacological modulation of pancreatic triacylglycerol lipase (PL) and α-amylase/α-glucosidase (Pharmaco-dynamic interaction)	Potentiation of combined drug effect	Moderate	Possible	Moderate	D (In vitro or animal study)	^11,15,16
Antidiabetic Medication	Decrease fasting blood glucose Possible through the presence of insulin-like substances in plants (flavonoids), which stimulate Beta-cells to produce more insulin (Pharmaco-dynamic interaction	Potentiation of combined drug effect (Hypo-glycemia)	Moderate	Possible	Moderate	D (In vitro or animal study)	^11,16,23
Levothyroxine	Increase the level of T3 and T4, possibly through an increase in the level of Thyroid peroxidase (TPO), which catalyses the biosynthesis of thyroid hormone (Pharmaco-dynamic interaction	Potentiation of levothyroxine activity	Moderate	Possible (limited studies)	Moderate (limited studies)	D (In vitro or animal study)	^12,13,17

Ammi visnaga

Ammi visnaga L. is a short biennial plant native to the Mediterranean area, commonly known as khella.²⁴ The oral decoction of khella has been utilized in both modern and traditional medicine for the treatment of various diseases and conditions, including cardiovascular disorders, respiratory conditions, kidney stones, and abdominal cramps, as well as antibacterial, antiviral, and antifungal activities.^25–27 Several studies have investigated the phytochemicals responsible for the pharmacological activity of the plant, including γ-pyrones such as visnadin, visnagin, and khellin, which exhibit vasodilating and bronchodilating effects, as well as coumarins, flavonoids, and essential oils, which demonstrate antibacterial and antioxidant properties.^25,28,29 The antilithiogenic activity of Ammi visnaga is primarily attributed to visnagin and khellin, which act through their vasodilating effect and interference with citrate metabolism, thereby inhibiting calcium oxalate crystallization.^27,30,31

The oral dose of khella extract is standardized to 12% khellin. An average dose of Ammi visnaga is stated to be 20 mg of the khellin component per day.²⁷ Regarding plant safety, Studies are conflicting. Some studies have reported hepatotoxicity at high, prolonged doses, as well as an increase in liver enzymes.^27,32,33 Another study showed no effect on the liver in a 28-day trial on rats³⁴; thus, it is essential to avoid using this herb in patients with liver function conditions and to monitor liver enzymes during use. Reports also stated its contraindication for use in pregnancy due to the uterine stimulant activity of khellin.^27,35 It was reported that the median lethal dose (LD50) was 3.6 g/kg for intraperitoneal administration and 10.1 g/kg for oral administration in rats.³⁶

Drug-herbal interactions for khella have not been extensively investigated; some of the listed interactions are based on studies proving its pharmacological activity, while other interactions are based on the actual references as presented in “Table 3”; and monitoring tips in Figure 3.

Figure 3.

Drug/ herbal interaction of Ammi visnaga monitoring tips (created using BioRender).

Table 3.

The Drug-Herbal Interactions of Ammi visnaga.

Conventional Medications	Interaction mechanism	Outcome	Interact rating	Occurrence	Severity	Level of evidence	Ref.
Antihypertensive medication	Vasodilation, possibly through calcium channel blocking activity (Pharmacodynamic interaction)	Theoretically Potentiation of effect hypotension	Moderate	Possible	Moderate	D (In vitro or animal study)	^25,26
Photosensitizing drugs (quinolone, sulfa, amitriptyline)	Khellin and the furocoumarin constituent are structurally similar to psoralen, thus increasing photosensitization (Pharmacodynamic interaction)	Increase skin sensitivity to sunlight	Moderate	Possible	Moderate	D (Anecdotal evidence)	²⁷
Hepatotoxic drugs (Paracetamol, amiodarone, INH, carbamazepine, etc)	Increase liver transaminases enzymes (Pharmacodynamic interaction)	Potentiation of the hepatotoxic effect of combining drugs	Moderate	Possible	High	B (Nonrandomized clinical trial)	³²
Digoxin	Visnadin has negative inotropic effects that might counter the effects of cardiac glycosides (Pharmacodynamic interaction)	Decrease the effectiveness of digoxin	Moderate	Possible	High	D (In vitro or animal study)	^35,37

Petroselinum sativum

Petroselinum sativum Hoffm. (synonyms of Petroselinum crispum), commonly known as parsley and belonging to the family Apiaceae, is a fragrant herb with a rich cultural history of use in traditional medicinal practices.³⁸ Parsley has its origins in the Mediterranean area but is now grown worldwide.³⁹ Traditionally, parsley has been used to manage various ailments, including diabetes, hyperlipidemia, hyperuricemia, renal disease, cardiovascular disease, and hypertension.⁴⁰ Several studies have reported the pharmacological activity of this herb, including antimicrobial, estrogenic activity, antioxidant, antiplatelet, antilithiatic, and diuretic properties.⁴¹ The phytochemical constituents of parsley include flavonoids, furanocoumarins, carotenoids, essential oils (phenylpropane and terpene compounds as major constituents), phytoestrogens, and minerals.⁴⁰ The role of Petroselinum sativum as an antilithic agent is thought to be through reducing urinary calcium excretion and alkalinizing the urine, thereby decreasing the formation of stones.^42,43

Regarding the safety of this herb, clinical data are lacking to provide dosing recommendations. In general, Petroselinum sativum is considered safe for use as a food, based on the U.S. Food and Drug Administration (FDA), and is likely safe when used in an appropriate amount for the short term with no toxicity reported.^44–47 A study performed in rats suggested a dose of 200–600 mg/kg body weight for the treatment of kidney stones.⁴² However, High doses of parsley extract, as 1 g/kg body weight, may lead to substantial increases in liver enzymes, indicating hepatotoxicity. In addition, the increase in blood urea nitrogen and creatinine levels suggests kidney toxicity.⁴⁸ Data also confirmed the unsafe use in pregnancy and possible congenital malformation.⁴⁹

Several drug-herbal interactions have been reported; detailed information is presented in “Table 4 and Figure 4”.

Figure 4.

Drug/herbal interaction of Petroselinum sativum and risk management (created using BioRender).

Table 4.

The Drug-Herbal Interactions of Petroselinum sativum.

Conventional Medications	Interaction mechanism	Outcome	Interact rating	Occurrence	Severity	Level of evidence	Ref.
Antiplatelets	Inhibition of platelet aggregation and an increase in bleeding time (Pharmacodynamic Interaction)	Risk of bleeding	Moderate	Possible	High	D (In vitro or animal study)	^49,50
Warfarin	Parsley contains vit K (Pharmacodynamic Interaction)	Theoretically, high amounts of parsley leaf and root might decrease the effects of warfarin.	Moderate	Possible	High	D (Theoretical, based on pharmacology)	³⁵
Estrogen	Parsley contains significant phytoestrogens that exhibit estrogen-like activity (Pharmacodynamic Interaction)	Theoretical possibility of modulating estrogen receptors	Moderate	Possible	Moderate	D (In vitro or animal study)	⁴⁸
Sirolimus	Inhibit cytochrome P450 3A4 (CYP3A4) and P-glycoprotein (P-gp) enzymes involved in the metabolism and transport of sirolimus (Pharmacokinetic Interaction)	Increase level of sirolimus	Moderate	Possible	Moderate	D (Anecdotal evidence)	⁵¹
Substrate for cytochrome P450 1A2 (CYP1A2)	Inhibition of CYP1A2 Pharmacokinetic Interaction	Increase the level of substrate in the body	Moderate	Possible	Moderate	D (Theoretical based on pharmacology)	⁵²
Aspirin	Aspirin might increase the severity of allergic reactions to parsley	Urticaria and swelling	Minore	unlikely	Moderate	D (Anecdotal evidence)	⁵³
Antidiabetic medication	Lower glucose level: Inhibition of gluconeogenesis and direct stimulation of glycolysis may be involved in the mechanism of action of this plant (Pharmacodynamic Interaction)	Potentiation of antidiabetic effect (hypoglycemia)	Moderate	Possible	Moderate	D (In vitro or animal study)	^54,55
Diuretics	Inhibiting the Na⁺/K⁺ pump decreases the reabsorption of sodium and potassium, resulting in an osmotic movement of water into the tubular lumen and promoting diuresis. (Pharmacodynamic interaction)	Parsley might enhance or interfere with the effects of diuretic drugs	Moderate	Possible	Moderate	D (Theoretical, based on pharmacology)	⁵⁶
Phenobarbital	Inhibition of cytochrome P450 Pharmacokinetic Interaction)	Increase the duration of pentobarbital effects	Moderate	Possible	High	D (In vitro or animal study)	⁵⁷
Methoxsalen	additive phototoxicity through parsley coumarins Pharmacodynamic Interaction)	Parsley may increase the photosensitizing effects of Methoxsalen	Moderate	Possible	Moderate	D (Theoretical, based on pharmacology)	⁵⁸

Senegalia Senegal (Acacia senegal)

Senegalia Senegal, also known as acacia gum or Arabic gum (AG), is an edible constituent widely used as an excipient in both the food and industrial sectors. AG is a gummy exudate derived from the air-dried sap exuded from the branches and trunk of Senegalia Senegal of the family Leguminosae.⁵⁹ Plant species of this genus are naturally found in tropical and subtropical regions worldwide, including Africa, Australia, Central America, the Middle East, and South Asia.⁶⁰ A literature review revealed the traditional use of this plant in managing gastrointestinal tract conditions, promoting oral hygiene, and addressing disorders such as obesity and diabetes. Reports also suggest its role in hyperlipidemia, gingival inflammation, and antibacterial activities, as well as its therapeutic role in managing chronic kidney conditions.^59–62 Its role in urolithiasis is not directly related to its effect on kidney stones, but it is prebiotic, anti-inflammatory, and antioxidant, which plays an essential role in preventing kidney damage.^61,63 GA reduced plasma urea and creatinine levels, improved creatinine clearance, and significantly altered electrolyte excretion, resulting in improved overall water and electrolyte balance in healthy mice.⁶¹ GA is a complex combination of polysaccharides and glycoproteins, which accounts for its water solubility and low viscosity. The main components are the arabinogalactan protein complex. This compound consists of several minerals, such as magnesium, calcium, and potassium salts of arabic acid.⁶²

Regarding safety, AG is widely identified as safe for human utilization and has been classified as “Generally Recognized As Safe” (GRAS) by the FDA in the United States. It is also considered safe for use as a food additive by the European Food Safety Authority.^61,64,65 According to references, it is considered safe to be taken orally in a dose of up to 30 grams of powdered gum daily for 3 months^66,67; however, reliable information on its use during pregnancy and lactation is not available.⁶⁵ Research is limited for typical dosing information.

The drug herbal interactions of AG are related to the suspending osmotic property in drug preparations. AG may enhance the bioavailability of water-insoluble drugs, such as naproxen, but reduce the absorption of polar drugs, like amoxicillin.⁶⁸ To avoid changes in absorption, it is advisable to take gum arabic 30–60 min after oral medications. These interactions are represented in “Table 5 and Figure 5.”

Figure 5.

The drug-herbal interactions of Arabic Gum and monitoring tips ( created using BioRender).

Table 5.

The Drug-Herbal Interactions of Arabic Gum (AG).

Conventional Medications	Interaction mechanism	Outcome	Interact rating	Occurrence	Severity	Level of evidence	Ref.
Amoxicillin	AG decreases the absorption of amoxicillin when taken concurrently (Pharmacokinetic Interaction)	Decrease the effect of amoxicillin	Moderate	Probable	Moderate	B (Lower quality RCT)	⁶⁸
Naproxen	Fibers in AG increase the absorption of water-insoluble medications as naproxen (Pharmacokinetic Interaction)	Increase naproxen bioavailability	Moderate	Possible	Moderate	B (Lower quality RCT)	⁶⁸

Tribulus terrestris

Tribulus terrestris (TT), commonly known as “Al-Gutub” in Iraq, manuscriptto the family Zygophyllaceae. TT is a small annual plant that grows in Mediterranean, subtropical, and desert climate regions worldwide, including India, China, the southern United States, Mexico, Spain, and Bulgaria.^69,70 Traditionally used as an aphrodisiac, in addition to other folk uses, including the management of kidney disorders, antioxidant, anti-inflammatory, respiratory, and skin conditions^71,72; it has also shown effectiveness as an antibacterial, antidiabetic, and cardioprotective agent.^71,73–75 Its role as an antilithiatic was documented by the fact that TT extract suppresses the formation and growth of calcium oxalate crystals, as well as having a protective effect at the cellular level.^69,76 A wide range of bioactive and chemically diverse phytoconstituents has been associated with the various uses of TT. These include steroidal saponins, flavonoids, tannins, terpenoids, glycosides, amide derivatives, amino acids, protein, polyphenol carboxylic acids, and alkaloids.^69,72

For the safety of TT extract, studies have shown that oral doses of 750–1500 mg per day are apparently safe for up to 90 days of use, as well as the powdered TT fruits in an oral dose of 6 g per day for 2 months; however, there is no documentation for its safety beyond three months of treatments.^77–80 Studies have found that chronic use of large doses can adversely affect liver and kidney function.⁸¹ While there are no available studies on the use during lactation, its use in pregnancy is not recommended due to its effect on fetal development.⁸²

Literature reveals that TT has a hormonal effect and is therefore used as an aphrodisiac, although drug interactions with hormones have not been investigated. Studies suggest its careful use due to its potential to disrupt the endocrine system.^83–85 Other studied interactions are illustrated in “Table 6 and Figure 6”.

Figure 6.

The drug-herbal interactions of Tribulus terrestris and monitoring tips (created using BioRender).

Table 6.

The Drug-Herbal Interactions of Tribulus terrestris.

Conventional Medications	Interaction Mechanism	Outcome	Interact rating	Occurrence	Severity	level of evidence	Ref.
Antidiabetic medication	Inhibit the gluconeogenesis, influence glucose metabolism in normal mice, and cause a significant decrease in the blood glucose level of diabetic mice delay the absorption of glucose by inhibiting β-glucosidase in the small intestine and lowering the postprandial glucose levels (Pharmacodynamic Interaction)	Increase the risk of hypoglycemia.	Moderate	possible	Moderate	D (In vitro or animal study)	^86,87
Metformin	Saponin content enhances the absorption of metformin from the intestine (Pharmacokinetic Interaction)	Increase the bioavailability of metformin	Moderate	Possible	Moderate	D (In vitro or animal study)	⁸⁸
Antihypertensive medication	Inhibiting angiotensin-converting enzyme (ACE) (Pharmacodynamic Interaction)	Might increase the risk of hypotension.	Moderate	Possible	Moderate	D (In vitro or animal study)	^89–92
Lithium	Reduce renal excretion of lithium (Pharmacokinetic Interaction)	Might increase the lithium	Moderate	Possible	Moderate	D (Theoretical, based on pharmacology)	⁹³
Statins	Moderate inhibitor of cytochrome P450 3A4 (Pharmacokinetic Interaction)	Increase risk of Rhabdomyolysis	Moderate	Possible	Sever	D (In vitro or animal study)	⁹⁴

Trigonella foenum-graecum

Trigonella foenum-graecum, commonly known as “halba” or “fenugreek,” is an annual plant of the family Leguminosae. It is grown in the Mediterranean region, Western Asia, and Southern Europe, and is a well-known spice in human food, as well as one of the oldest botanical herbs used in ancient history.^95,96 Traditionally, fenugreek has been used to treat different conditions, including digestive disorders, skin inflammation, as a demulcent, a lactation stimulant, and a laxative.^95,97 Several pharmacological properties have been documented for fenugreek, including antioxidant, anti-inflammatory, antihyperlipidemic, antidiabetic, antibacterial, and anticancer effects.^98,99 These medicinal properties are attributed to the bioactive compounds, including alkaloids (trigonelline, choline), steroidal sapogenins (yamogenin, diosgenin, smilagenin, sarsasapogenin), saponins, flavonoids (quercetin, rutin, vitexin), fiber, lipids, and amino acids.¹⁰⁰ Its role in kidney stone prevention is attributed to the ability of the seed extract to reduce and prevent the growth of calcium oxalate crystals, a mechanism thought to be mediated through diuretic and antioxidant activity, thereby lowering the risk of stone formation.^100,101

In regard to the safety of this herb extract, references suggested its safety when used in an appropriate amount, which is represented by fenugreek seed powder in an oral dose of 5–10 grams daily for up to 3 years, and fenugreek seed extract in a dose of 1 gram daily for up to 3 months is considered safe.^102–106 A study based on an animal model suggested that oral doses for humans should not exceed 350 mg/kg (21 g per 60 kg) to prevent accidental overdose.¹⁰⁷

The use of fenugreek during pregnancy in an amount greater than that found in food has potential oxytocic and uterine stimulant activity, and cases have been reported for congenital malformations.^107,108 The use during lactation is possibly safe if used for a short term, although most available clinical data lack testing on lactating women or nursing infants.^109,110 Some studies suggest that a dose of 1725 mg, administered three times daily for three weeks, may be considered safe.¹¹¹

The drug herbal interaction of fenugreek is represented in “Table 7 and Figure 7.”

Figure 7.

The drug-herbal interactions of Trigonella foenum-graecum and monitoring tips (created using BioRender).

Table 7.

The Drug-Herbal Interactions of Trigonella foenum-graecum.

Conventional Drug	Mechanism of interaction	Outcome	Interac rating	occurrence	Severity	level of evidence	Ref.
Anti diabetic Medication	Fenugreek seeds stimulate insulin release from beta cells and improve insulin signaling, glucagon suppression, and delay gastric emptying (Pharmaco-dynamic Interaction)	Increase the risk of hypoglycemia.	Moderate	Probable	Moderate	B (Nonrandomized clinical trial)	^95,112
Antihypertensive medication (metoprolol, amlodipine, losartan)	Decrease systolic blood pressure (mechanism possibly through Inhibition of CYP3A4 and CYP2C9 pharmacokinetic interaction)	Theoretically, fenugreek seed might increase the hypotensive effects of combined drug	Moderate	Probable	Moderate	B (Nonrandomized clinical trial)	^113–116
Sildenafil	Fenugreek has the potential to affect sildenafil absorption (Pharmacokinetic Interaction)	Theoretically, concurrent use of sildenafil and fenugreek might reduce the levels and therapeutic effects of sildenafil.	Moderate	Possible	Moderate	D (In vitro or animal study)	¹¹⁷
Theophylline	Modulating CYP1A2 (Pharmacokinetic Interaction)	Theoretically, fenugreek may reduce the levels and clinical effects of theophylline.	Moderate	Possible	Moderate	D (In vitro or animal study)	¹¹⁸
Phenytoin	Increased clearance of Phenytoin (Pharmacokinetic Interaction)	Theoretically, fenugreek might decrease plasma levels of phenytoin.	Moderate	Possible	Moderate	D (In vitro or animal study)	¹¹⁹
Clopidogrel	Theoretically, fenugreek may have antiplatelets activity due to the presence of coumarin -like phytochemicals (Pharmacodynamic Interaction) more over Fenugreek can alter theCYP450 thereby altering level of Clopidogrel (Pharmacokinetic interaction)	Alter the effect of Clopidogrel and prolonged bleeding time	Moderate	Possible	Moderate	D (In vitro or animal study)	¹²⁰
Warfarin	Some fenugreek constituents have antiplatelet effects coumarin -like phytochemicals (Pharmacodynamic Interaction)	Theoretically, fenugreek may have additive effects with warfarin, potentially increasing the international normalized ratio (INR).	Moderate	Possible	High	D (Anecdotal evidence)	^121,122
Sertraline	Fenugreek may potentiate the serotonergic effect of sertraline due to its phytoconstituent as 4-hydroxyisoleucine (Pharmacodynamic Interaction	Serotonin syndrome	Moderate	Possible	Moderate	D (In vitro or animal study)	¹²³

Zea mays (Corn Silk)

Corn silk (CS), the elongated stigma of the female flower of Zea mays (F. Poaceae), is considered the third most widely grown crop worldwide and a primary cereal in various countries and regions, including Southern and Eastern Africa, Central America, and Mexico.¹²⁴ It is a widely available agricultural byproduct often considered a waste product and traditionally used in the management of diabetes, obesity, prostate disorders, as a diuretic, and kidney disorders.¹²⁵ Recent research has documented the pharmacological activities of CS extract, including antioxidant, anti-inflammatory, anticancer, hypotensive, anti-diabetic, hypolipidemic, antibacterial, antifatigue, antidepressant, and anticoagulant properties.^125–128 The bioactive components of CS are reported to include polyphenolic compounds, flavonoids, tannins, alkaloids, volatile oils, steroids (sitosterol and stigmasterol), saponins, proteins, various minerals, and vitamins.^128–130 Regarding the antiurolithiatic activity, a recent study reported that the mechanism involved both diuretic activity and alkalinization of urinary pH, thereby preventing the formation of calcium oxalate crystals. Moreover, CS antibacterial and antioxidant activity aid in kidney protection.¹³¹

Concerning the safe consumption of this herb, references suggest that corn silk and its extract, when used in amounts found in food, have a Generally Recognized as Safe (GRAS) status in the US.⁴⁴ Recent studies showed that an oral dose of CS extract at 500 mg/kg body weight is generally safe, but doses equal to or higher than 2000 mg/kg for longer durations is considered toxic and should be avoided; thus, the study recommended a safe dose of less than 1000 mg/kg body weight for the therapeutic purposes.^128,132 The use in pregnancy in larger amounts is considered unsafe due to the uterine stimulant effects of CS¹³³; however, there is no available data on its use during lactation.

The drug-herbal interaction reported in the literature is demonstrated in “Table 8 and Figure 8.”

Figure 8.

The drug-herbal interactions of Zea mays and monitoring tips (created using BioRender).

Table 8.

The Drug-Herbal Interactions of Zea mays.

Conventional Drug	Mechanism of interaction	Outcome	Interaction rating	Occurrence	Severity	level of evidence	Ref.
Hypoglycemic medication	CS inhibited JNK-IRS-GLUT4 signal transduction in skeletal muscle via antioxidative effects. Inhibition of the α-amylase activity and α-glucosidase activity. increases hepatic glycogen by inhibiting glucokinase Inhibiting gluconeogenesis (Pharmacodynamic Interaction)	Hypoglycemia	Moderate	Possible	Moderate	D (Theoretical based on pharmacology)	^134–136
Antihypertensive medication	Potassium-induced natriuresis; also, via Angiotensin-converting enzyme (ACE) inhibitory phytopeptide in corn silk (Pharmacodynamic Interaction)	Potentiation of antihypertensive drugs leading to hypotension	Moderate	Possible	Moderate	D (Theoretical based on pharmacology)	^137–139
Corticosteroids	Potassium-induced natriuresis and diuresis by corn silk extract will counteract the sodium-retaining effects of mineralocorticoids (Pharmacodynamic interaction)	Increase the risk of hypokalemia.	Moderate	Possible	High	D (Theoretical based on pharmacology)	¹³⁷
Diuretics	Increases urine volume and promotes the urinary excretion of sodium and potassium (Pharmacodynamic interaction)	Hyponatremia ; hypokalemia and dehydration.	Moderate	Possible	High	D (Theoretical based on pharmacology)	¹³⁷
Warfarin	Contain Vitamin K phytochemicals that antagonized the effect of warfarin (Pharmacodynamic interaction)	May reduce the anticoagulant effect of warfarin	Moderate	Likely	Mild	D (Theoretical based on pharmacology)	¹⁴⁰

Clinical Implications of Herb–Drug Interactions

The prevalence of botanical use of herbs has increased significantly worldwide, with a public usage rate as high as 80%, according to the literature.¹⁴¹ People culturally believe in the safety of these natural products, and this belief has extended from early civilizations to the present day.^142–144 Patients often do not disclose their use of supplements and herbal products to their healthcare providers due to this belief and a lack of awareness of potential interactions that could occur with their current disease state or conventional medications.^145,146 This practice exposes patients to unwanted side effects and reactions that put them at risk and hinder the management of their condition by primary care personnel. Several research studies have addressed this risk and discussed herbal drug interactions in general^147,148; however, to the author's knowledge, there have been limited studies that specifically examined herbal interactions in the management of kidney stones. Thus, this review aimed to discuss the potential drug-herbal interactions for commonly used herbs in the management of urolithiasis in Iraq, as this condition is one of the major urological conditions in this region.¹⁰ This review is crucial for clinicians and pharmacists to understand the potential interactions between patients’ medications and herbal products, thereby preventing adverse effects on patient health and providing guidance on monitoring and managing these interactions. Seven medicinal herbs were selected for this review based on a previous survey on the most commonly used herbs in the management of kidney stones.¹⁰ These herbs were selected based on the highest use value (UV) reported in the mentioned study. An extensive review of various data sources was then conducted, examining related studies in this context. Some of the interactions were based on the theoretical explanation of the pharmacological properties of the studied herbs, such as A. capillus-veneris and Ammi visnaga, as there were limited studies regarding the safety of consuming these products with other medications, as compared to the rest of the studied herbs, where more articles were documenting their interactions. The results showed that the most frequently interacting medications were related to cardiovascular disorders (anticoagulants and antihypertensive medications) and Diabetes (antidiabetic medications), which are the two most common disorders affecting patients worldwide,¹⁴⁹ with some drugs having low therapeutic indices (as warfarin and digoxin).¹⁵⁰ These interactions would affect patients of different age levels, particularly the elderly, due to their age-associated physiological alterations in organ systems, which in turn significantly modify drug pharmacokinetics and pharmacodynamics, thus imposing an even greater risk of harmful effects.¹⁵¹

The literature survey also explained the mechanism of drug-herb interactions as cited in the Tables (2-8), but the exact mechanisms behind many reported interactions between drugs and herbal medicines remain largely unclear.¹⁵² This may be due to the fact that herbal products consist of different phytochemicals that exert varying effects, making it challenging to evaluate these interactions based on the percentage of these chemicals in the studied herb.^150,153 The chemical metabolite profiles are also influenced by plant species, chemotype, cultivation conditions, harvesting practices, extraction, and preparation methods.¹⁵² The difficulty extends to the fact that most herbs are not used as a single entity but rather as mixtures of herbs in a single herbal product, thus predicting the exact influence on concurrent medication use is difficult. Some of the listed interactions in this review were related to the pharmacokinetic interactions, such as the modulation of drug absorption (as Senegalia Senegal, Tribulus terrestris, and Trigonella foenum-graecum) or metabolism through inhibiting CYP450 (Petroselinum sativum, Tribulus terrestris, Trigonella foenum-graecum) or alteration in drug excretion (Tribulus terrestris, Trigonella foenum-graecum, and Zea mays); other interactions are pharmacodynamic, which is represented by the synergistic effect of the herbal products, thus potentiate the effect of the concurrent drug.

Conclusion

This review highlights potential drug-herbal interactions associated with the use of commonly used medical herbs in the management of kidney stones. It also emphasizes raising awareness among healthcare practitioners as well as the public regarding the possible potential risks of using herbs concurrently with conventional therapy and highlights the importance of reporting any interactions or adverse reactions that may result from this use.

Footnotes

Acknowledgment

The author hereby acknowledges Assistant Professor Dr Salam Ahjel for his help in providing some of the references needed for this review as well as the Library staff In Al-Zahrawi University/ College of Pharmacy

ORCID iD

Suhad Sami Humadi

Funding

The author received no financial support for the research, authorship, and/or publication of this article.

Declaration of Conflicting Interests

The author declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

References

Peerapen

Thongboonkerd

. Kidney stone prevention. Adv Nutrit. 2023;14(3):555-569.

Sánchez

Sarano

del Valle

. Nephrolithiasis: pathophysiology, metabolic evaluation, and therapy. Actualizaciones en Osteología. 2011;7(3):195-234.

López

Hoppe

. History, epidemiology and regional diversities of urolithiasis. Pediatr Nephrol. 2010;25(1):49-59.

Alsaedi

Jamal

Al-Windawi

. The prevalence of hypertension and nephrolithiasis in a sample of Iraqi patients with autosomal-dominant polycystic kidney disease. Saudi J Kidney Dis Transpl. 2011;22(5):1044-1045.

Fadhil

. A study on renal stones incidence with regard to age, gender and chemical composition of stones in Western Iraq. Int J Health Sci (Qassim). 2022;6(S1):9814-9818.

Cupisti

Giannese

D’Alessandro

, et al.

Kidney stone prevention: is there a role for complementary and alternative medicine?

Nutrients. 2023;15(4):877.

Wanwimolruk

Prachayasittikul

. Cytochrome P450 enzyme-mediated herbal drug interactions (Part 1). EXCLI J. 2014;13:347-391.

Alhur

. Community insights on drug–herbal interactions: a study from Hail, Saudi Arabia. Cureus. 2024;16(10):e72529.

Younus

Ibrahim

. Pharmacovigilance for herbal medicines in Iraq. In: Barnes

, ed. Pharmacovigilance for Herbal and Traditional Medicines. Springer Nature; 2022:385-394.

10.

Humadi

. Ethnobotanical study of medicinal plants used by Iraqi herbalists in the management of nephrolithiasis: a cross-sectional survey conducted in Southern Iraq (Karbala). Plant Sci Today. 2024;11(2):117-124.

11.

Rastogi

Pandey

Rawat

AKS

. Ethnopharmacological uses, phytochemistry and pharmacology of genus Adiantum: a comprehensive review. J Ethnopharmacol. 2018;215:101-119.

12.

Vijayalakshmi

Kiran Kumar

. Evaluation of goitrogenic and antithyroidal effect of the fern Adiantum capillus-veneris. Revista Brasileira de Farmacognosia. 2013;23(5):802-810.

13.

Kashkooe

Sardari

Mehrabadi

Zarshenas

. A review of pharmacological properties and toxicological effects of Adiantum capillus-veneris L. Curr Drug Discovery Technol. 2021;18(2):186-193.

14.

Khoramian

Sajjadi

S-E

Minaiyan

. Anti-inflammatory effect of Adiantum capillus-veneris hydroalcoholic and aqueous extracts on acetic acid-induced colitis in rats. Avicenna J Phytomed. 2020;10(5):492-503.

15.

Verma

. Hypolipidemic and antiatherogenic effects of Adiantum capillus-veneris extract in cholesterol-fed rats. Atherosclerosis. 2020;315:e167.

16.

Kasabri

Al-Hallaq

Bustanji

Abdul-Razzak

Abaza

Afifi

. Antiobesity and antihyperglycaemic effects of Adiantum capillus-veneris extracts: in vitro and in vivo evaluations. Pharm Biol. 2017;55(1):164-172.

17.

Qureshi

Khan

Ahmad

Khan

Zafar

. Evaluation of goitrogenic and antithyroidal effect of the fern Adiantum capillus-veneris. J Ethnopharmacol. 2009;125(2):198-201.

18.

Noubarani

Rostamkhani

Erfan

, et al. Effect of Adiantum capillus-veneris Linn on an animal model of testosterone-induced hair loss. Iran J Pharm Res. 2014;13(Suppl):113-118.

19.

Ahmed

Jahan

Wadud

Bilal

Hajera

. In vitro effect of hydro-alcoholic extract of Adiantum capillus-veneris Linn. on calcium oxalate crystallization. Int J Green Pharm. 2013;7(2):106-110.

20.

Parveen

Wadud

Shamsi

Parveen

. Antilithiatic activity of a non-pharmacopoeial Unani formulation in chemically induced urolithiasis in rats. J Complementary Integr Med. 2021;18(4):685-694.

21.

Samandarian

Soltani

Hajhashemi

, et al. Efficacy of an oral solution containing five herbal extracts in the treatment of urolithiasis: a randomized, single-blind, placebo-controlled clinical trial. J Res Pharm Pract. 2023;12(3):96-103.

22.

Nazim

Aslam

Chaudhary

. Hansraj (Adiantum capillus-veneris): a review. J Drug Deliv Therapeut. 2018;8(5-s):105-109.

23.

Dehdari

Hajimehdipoor

. Medicinal properties of Adiantum capillus-veneris Linn. in traditional medicine and modern phytotherapy: a review article. Iran J Public Health. 2018;47(2):188-197.

24.

Golkar

Akbari

Bazarganipour

Javed

. Biochemical and phytochemical responses of Ammi visnaga L. (Apiaceae) callus culture elicited by SiO₂ and graphene oxide–SiO₂ nanoparticles. Plant Physiol Biochem. 2023;200:107741.

25.

Khalil

Bishr

Desouky

Salama

. Ammi visnaga L., a potential medicinal plant: a review. Molecules. 2020;25(2):301.

26.

Amtaghri

Qabouche

Slaoui

Eddouks

. Potential antihypertensive activity of the aqueous extract of Ammi visnaga and its effect on ACE2 in rats. Cardiovasc Hematol Disorders–Drug Targets. 2023;23(4):277-284.

27.

Bhagavathula

Al Khatib

AJM

Elnour

Al Kalbani

Shehab

. Ammi visnaga in treatment of urolithiasis and hypertriglyceridemia. Pharmacognosy Res. 2014;7(4):397-400.

28.

Sellami

Napolitano

Masullo

Smiti

Piacente

Pizza

. Influence of growing conditions on metabolite profile of Ammi visnaga umbels with special reference to bioactive furanochromones and pyranocoumarins. Phytochemistry. 2013;95:197-206.

29.

Ahmed

SST

Fahim

Youssif

, et al. Metabolomics of the secondary metabolites of Ammi visnaga L. roots (family Apiaceae) and evaluation of their biological potential. S Afr J Bot. 2022;149:860-869.

30.

Khan

Assiri

Al-Afghani

Maghrabi

. Inhibition of oxalate nephrolithiasis with Ammi visnaga (Al-Khillah). Int Urol Nephrol. 2001;33(4):605-608.

31.

Byer

Khan

. Citrate provides protection against oxalate and calcium oxalate crystal-induced oxidative damage to renal epithelium. J Urol. 2005;173(2):640-646.

32.

Blumenthal

, ed. The complete German Commission E monographs: Therapeutic guide to herbal medicines. S. Klein, trans. American Botanical Council; 1998.

33.

Ndayambaje

Wahnou

Sow

, et al. Exploring the multifaceted effects of Ammi visnaga: subchronic toxicity, antioxidant capacity, immunomodulatory, and anti-inflammatory activities. J Toxicol Environ Health, Part A. 2023;87(4):150-165.

34.

Koriem

KMM

Arbid

El-Attar

. Acute and subacute toxicity of Ammi visnaga on rats. Interdiscip Toxicol. 2019;12(1):26-35.

35.

Brinker

. Herb Contraindications and Drug Interactions. 2nd ed. Eclectic Medical Publications; 1998.

36.

Jouad

Maghrani

Eddouks

. Hypoglycemic effect of aqueous extract of Ammi visnaga in normal and streptozotocin-induced diabetic rats. J Herb Pharmacother. 2002;2(4):19-29.

37.

Duarte

Torres

Zarzuelo

. Cardiovascular effects of visnagin on rats. Planta Med. 2000;66(1):35-39.

38.

Slighoua

Mahdi

Amrati

, et al. Assessment of in vivo estrogenic and anti-inflammatory activities of the hydro-ethanolic extract and polyphenolic fraction of parsley (Petroselinum sativum Hoffm. J Ethnopharmacol. 2021;265:113290.

39.

Mahmood

Hussain

Malik

. Critique of medicinal conspicuousness of parsley (Petroselinum crispum): a culinary herb of Mediterranean region. Pak J Pharm Sci. 2014;27(1):193-202.

40.

Mahdi

Imbimbo

Annaz

, et al. Profiling of Petroselinum sativum (Mill.) Fuss phytoconstituents and assessment of their biocompatibility, antioxidant, anti-aging, wound healing, and antibacterial activities. Front Nutr. 2024;11:1338482.

41.

Farzaei

Abbasabadi

Ardekani

MRS

Rahimi

Farzaei

. Parsley: a review of ethnopharmacology, phytochemistry and biological activities. J Tradit Chin Med. 2013;33(6):815-826.

42.

Saeidi

Bozorgi

Zendehdel

Mehrzad

. Therapeutic effects of aqueous extracts of Petroselinum sativum on ethylene glycol-induced kidney calculi in rats. Urol J. 2012;9(1):361-366.

43.

Al-Yousofy

Gumaih

Ibrahim

Alasbahy

. Parsley! Mechanism as antiurolithiasis remedy. Am J Clin Exp Urol. 2017;5(3):55-62.

44.

Electronic Code of Federal Regulations. (2025). Title 21, Part 182: Substances generally recognized as safe [Webpage]. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=182.

45.

McGuffin

Hobbs

Upton

Goldberg

, eds. American Herbal Products Association's Botanical Safety Handbook. CRC Press; 1997.

46.

Al-Howiriny

Al-Sohaibani

El-Tahir

Rafatullah

. Prevention of experimentally induced gastric ulcers in rats by an ethanolic extract of parsley (Petroselinum crispum). Saudi J Gastroenterol. 2003;9(3):123-127.

47.

Meyer

Bolarinwa

Wolfram

Linseisen

. Bioavailability of apigenin from apiin-rich parsley in humans. Ann Nutr Metab. 2006;50(3):167-172.

48.

Alobaidi

. Renal health benefits and therapeutic effects of parsley (Petroselinum crispum): a review. Front Med (Lausanne). 2024;11:1494740.

49.

Chuang

Doyle

Wang

Chen

. Herbal medicines used during the first trimester and major congenital malformations: an analysis of data from a pregnancy cohort study. Drug Saf. 2006;29(6):537-548.

50.

Gadi

Bnouham

Aziz

, et al. Parsley extract inhibits in vitro and ex vivo platelet aggregation and prolongs bleeding time in rats. J Ethnopharmacol. 2009;125(1):170-174.

51.

Kurtaran

Koc

Aksun

Yildirim

Yilmaz

ŞR

Erdem

. Petroselinum crispum, a commonly consumed food, affects sirolimus level in a renal transplant recipient: a case report. Ther Adv Drug Saf. 2021;12:20420986211009358.

52.

Peterson

Lampe

Bammler

Gross-Steinmeyer

Eaton

. Apiaceous vegetable constituents inhibit human cytochrome P-450 1A2 (hCYP1A2) activity and hCYP1A2-mediated mutagenicity of aflatoxin B1. Food Chem Toxicol. 2006;44(9):1474-1484.

53.

Eberhard

Gall

Müller

Möller

. Dramatic augmentation of a food allergy by acetylsalicylic acid. J Allergy Clin Immunol. 2000;105(4):844.

54.

Yanardag

Bolkent

Tabakoglu-Oguz

Ozsoy-Sacan

. Effects of Petroselinum crispum extract on pancreatic β cells and blood glucose of streptozotocin-induced diabetic rats. Biol Pharm Bull. 2003;26(8):1206-1210.

55.

Ozsoy-Sacan

Yanardag

Orak

Ozgey

Yarat

Tunali

. Effects of parsley (Petroselinum crispum) extract versus glibornuride on the liver of streptozotocin-induced diabetic rats. J Ethnopharmacol. 2006;104(1–2):175-181.

56.

Kreydiyyeh

Usta

. Diuretic effect and mechanism of action of parsley. J Ethnopharmacol. 2002;79(3):353-357.

57.

Jakovljevic

Raskovic

Popovic

Sabo

. The effect of celery and parsley juices on pharmacodynamic activity of drugs involving cytochrome P450 in their metabolism. Eur J Drug Metab Pharmacokinet. 2002;27(3):153-156.

58.

Boffa

Gilmour

Ead

. Celery soup causing severe phototoxicity during PUVA therapy. Br J Dermatol. 1996;135(2):334.

59.

Lopez-Torrez

Nigen

Williams

Doco

Sanchez

. Acacia senegal vs. Acacia seyal gums – Part 1: composition and structure of hyperbranched plant exudates. Food Hydrocolloids. 2015;51:41-53.

60.

Ashour

Fatima

Imran

Ghoneim

Alshehri

Shakeel

. A review on the main phytoconstituents, traditional uses, inventions, and patent literature of gum Arabic emphasizing Acacia seyal. Molecules. 2022;27(4):1171.

61.

Alobaidi

. Therapeutic potential of gum Arabic (Acacia senegal) in chronic kidney disease management: a narrative review. J Clin Med. 2024;13(19):5778.

62.

Al-Jubori

Ahmed

NTB

Albusaidi

Madden

Das

Sirasanagandla

. The efficacy of gum Arabic in managing diseases: a systematic review of evidence-based clinical trials. Biomolecules. 2023;13(1):138.

63.

Lakshmanan

Al Za’abi

Ali

Terranegra

. The influence of the prebiotic gum acacia on the intestinal microbiome composition in rats with experimental chronic kidney disease. Biomed Pharmacother. 2021;133:110992.

64.

Phillips

. Biofunctional behaviour and health benefits of a specific gum arabic. Food Hydrocoll. 2011;25(2):165-169.

65.

Mortensen

Aguilar

Crebelli

, et al. Re-evaluation of acacia gum (E 414) as a food additive. EFSA J. 2017;15(4):e04741.

66.

Babiker

Merghani

Elmusharaf

, et al. Effects of gum Arabic ingestion on body mass index and body fat percentage in healthy adult females: two-arm randomized, placebo-controlled, double-blind trial. Nutr J. 2012;11:111.

67.

Babiker

Elmusharaf

Keogh

Banaga

Saeed

. Metabolic effect of gum Arabic (Acacia senegal) in patients with type 2 diabetes mellitus (T2DM): randomized, placebo-controlled, double-blind trial. Func Foods Health Dis. 2017;7(3):222-234.

68.

Eltayeb

Awad

Elderbi

Shadad

. Effect of gum arabic on the absorption of a single oral dose of amoxicillin in healthy Sudanese volunteers. J Antimicrob Chemother. 2004;54(2):577-578.

69.

Chhatre

Nesari

Somani

Kanchan

Sathaye

. Phytopharmacological overview of Tribulus terrestris. Pharmacogn Rev. 2014;8(15):45-51.

70.

Campanelli

De Thomasis

Tenaglia

. Priapism caused by Tribulus terrestris. Int J Impot Res. 2016;28(1):39-40.

71.

Saeed

Munawar

, et al. Promising phytopharmacology, nutritional potential, health benefits, and traditional usage of Tribulus terrestris L. herb. Heliyon. 2024;10(4):e25549.

72.

Zhu

Meng

Dong

. A review of traditional pharmacological uses, phytochemistry, and pharmacological activities of Tribulus terrestris. Chem Cent J. 2017;11(1):60.

73.

Ercan

. Inhibitory effects of chickpea and Tribulus terrestris on lipase, α-amylase and α-glucosidase. Food Chem. 2016;205:163-169.

74.

Zhang

Feng

. Effects of saponins from Tribulus terrestris on postprandial blood glucose levels in normal and type 2 diabetic rats. Pract Pharm Clin Remed. 2012;15(1):1-3.

75.

Song

Zhang

, et al. Protection of gross saponins of Tribulus terrestris (GSTT) on cardiac ischemia–reperfusion injury. Chin Trad Herbal Drugs. 2010;41(8):1326-1329.

76.

Aggarwal

Tandon

Singla

Tandon

. Diminution of oxalate-induced renal tubular epithelial cell injury and inhibition of calcium oxalate crystallization in vitro by aqueous extract of Tribulus terrestris. Int Braz J Urol. 2010;36(4):480-489.

77.

Brown

Vukovich

Reifenrath

, et al. Effects of anabolic precursors on serum testosterone concentrations and adaptations to resistance training in young men. Int J Sport Nutr Exerc Metab. 2000;10(3):340-359.

78.

Postigo

Lima

Yamada

, et al. Assessment of the effects of Tribulus terrestris on sexual function of menopausal women. Revista Brasileira de Ginecologia e Obstetrícia. 2016;38(3):140-146.

79.

Vale

FBC

Zanolla Dias de Souza

Rezende

Geber

. Efficacy of Tribulus terrestris for the treatment of premenopausal women with hypoactive sexual desire disorder: a randomized double-blinded, placebo-controlled trial. Gynecol Endocrinol. 2018;34(5):442-445.

80.

Siddiqui

Itrat

Mobeen

Khan

. Efficacy of khar-i-khasak (Tribulus terrestris Linn.) in prehypertension: a randomized, double-blind, placebo-controlled trial. J Complementary Integr Med. 2021;18(4):763-769.

81.

Gauthaman

Adaikan

. Effect of Tribulus terrestris on nicotinamide adenine dinucleotide phosphate diaphorase activity and androgen receptors in rat brain. J Ethnopharmacol. 2005;96(1–2):127-132.

82.

Walker

Bird

Flora

O'Sullivan

. Some effects of feeding Tribulus terrestris, Ipomoea lonchophylla and the seed of Abelmoschus ficulneus on fetal development and the outcome of pregnancy in sheep. Reprod Fert Dev. 1992;4(2):135-144.

83.

Gauthaman

Ganesan

. The hormonal effects of Tribulus terrestris and its role in the management of male erectile dysfunction—an evaluation using primates, rabbit and rat. Phytomedicine. 2008;15(1–2):44-54.

84.

Ghosian Moghaddam

Khalili

Maleki

Ahmad Abadi

. The effect of oral feeding of Tribulus terrestris L. on sex hormone and gonadotropin levels in addicted male rats. Int J Fertil Steril. 2013;7(1):57-62.

85.

Abudayyak

Jannuzzi

Özhan

Alpertunga

. Investigation on the toxic potential of Tribulus terrestris in vitro. Pharm Biol. 2015;53(4):469-476.

86.

Samani

Jokar

Soveid

Heydari

Mosavat

. Efficacy of the hydroalcoholic extract of Tribulus terrestris on the serum glucose and lipid profile of women with diabetes mellitus: a double-blind randomized placebo-controlled clinical trial. J Evid Based Complementary Altern Med. 2016;21(4):NP91-NP97.

87.

Samani

Jokar

Soveid

Heydari

Mosavat

. Efficacy of Tribulus terrestris extract on the serum glucose and lipids of women with diabetes mellitus. Iran J Med Sci. 2016;41(3, Suppl.):S5.

88.

Ayyanna

Mohan Rao

GCM

Sasikala

Somasekhar

Arun Kumar

Pradeep Kumar

MVS

. Absorption enhancement studies of metformin hydrochloride by using Tribulus terrestris plant extract. Int J PharmTech Res. 2012;4(1):4118-4125.

89.

Sharifi

Darabi

Akbarloo

. Study of antihypertensive mechanism of Tribulus terrestris in 2K1C hypertensive rats: role of tissue ACE activity. Life Sci. 2003;73(23):2963-2971.

90.

Arafa

Amin

Samir

, et al. Protective effects of Tribulus terrestris extract and angiotensin blockers on testis steroidogenesis in copper-overloaded rats. Ecotoxicol Environ Saf. 2019;178:113-122.

91.

Kamrani Rad

Javadi

Hayes

Karimi

. Potential angiotensin converting enzyme (ACE) inhibitors from Iranian traditional plants described by avicenna's Canon of Medicine. Avicenna J Phytomed. 2019;9(4):291-309.

92.

Siddiqui

Itrat

Mobeen

Khan

. Efficacy of Khār-i-khasak (Tribulus terrestris Linn.) in prehypertension: a randomized, double-blind, placebo-controlled trial. J Complementary Integr Med. 2021;18(4):783-789.

93.

Al-Ali

Wahbi

Twaij

Al-Badr

. Tribulus terrestris: preliminary study of its diuretic and contractile effects and comparison with Zea mays. J Ethnopharmacol. 2003;85(2-3):257-260.

94.

Huff

Karpinska-Leydier

Maddineni

Begosh-Mayne

. Rhabdomyolysis risk: the dangers of Tribulus terrestris, an over-the-counter supplement. Am J Case Rep. 2024;25:e943492.

95.

Haxhiraj

White

Terry

. The role of fenugreek in the management of type 2 diabetes. Int J Mol Sci. 2024;25(13):6987.

96.

Meghwal

Goswami

. A review on the functional properties, nutritional content, medicinal utilization and potential application of fenugreek. J Food Process Technol. 2012;3:1-10.

97.

Dharajiya

Jasani

Khatrani

Kapuria

Pachchigar

Patel

. Evaluation of antibacterial and antifungal activity of fenugreek (Trigonella foenum-graecum) extracts. Int J Pharm Pharmaceut Sci. 2016;8(4):212-217.

98.

Sarker

Ray

Dutta

Rouf

Uddin

. Antidiabetic potential of fenugreek (Trigonella foenum-graecum): a magic herb for diabetes mellitus. Food Sci Nutr. 2024;12(10):7108-7136.

99.

Wani

Kumar

. Fenugreek: a review on its nutraceutical properties and utilization in various food products. J Saudi Soc Agric Sci. 2018;17(2):97-106.

100.

Visuvanathan

Than

LTL

Stanslas

Chew

Vellasamy

. Revisiting Trigonella foenum-graecum L.: pharmacology and therapeutic potentialities. Plants. 2022;11(11):1450.

101.

Laroubi

Touhami

Zeggwagh

Haloui

Lahlou

Chait

. Prophylaxis effect of Trigonella foenum-graecum L. seeds on renal stone formation in rats. Phytother Res. 2007;21(10):921-925.

102.

Neelakantan

Narayanan

de Souza

van Dam

. Effect of fenugreek (Trigonella foenum-graecum L.) intake on glycemia: a meta-analysis of clinical trials. Nutr J. 2014;13:7.

103.

Nathan

Panjwani

Mohan

Joshi

Thakurdesai

. Efficacy and safety of standardized extract of Trigonella foenum-graecum L. seeds as an adjuvant to L-Dopa in the management of patients with Parkinson's disease. Phytother Res. 2014;28(2):172-178.

104.

Hassanzadeh Bashtian

Emami

Mousavifar

Esmaily

Mahmoudi

Mohammad Poor

. Evaluation of fenugreek (Trigonella foenum-graecum L.) seeds extract on insulin resistance in women with polycystic ovarian syndrome. Iran J Pharm Res. 2013;12(2):475-481.

105.

Swaroop

Jaipuriar

Gupta

, et al. Efficacy of a novel fenugreek seed extract (Trigonella foenum-graecum, Furocyst) in polycystic ovary syndrome (PCOS). Int J Med Sci. 2015;12(10):825-831.

106.

Gong

Fang

Dong

Wang

. Effect of fenugreek on hyperglycaemia and hyperlipidemia in diabetes and prediabetes: a meta-analysis. J Ethnopharmacol. 2016;194:260-268.

107.

Ouzir

El Bairi

Amzazi

. Toxicological properties of fenugreek (Trigonella foenum-graecum). Food Chem Toxicol. 2016;96:145-154.

108.

Khalki

Bennis

Sokar

Ba-M’hamed

. The developmental neurobehavioral effects of fenugreek seeds on prenatally exposed mice. J Ethnopharmacol. 2012;139(2):672-677.

109.

Gabay

. Galactogogues: medications that induce lactation. J Hum Lact. 2002;18(3):274-279.

110.

Turkyilmaz

Onal

Hirfanoglu

, et al. The effect of galactagogue herbal tea on breast milk production and short-term catch-up of birth weight in the first week of life. J Altern Complement Med. 2011;17(2):139-142.

111.

Reeder

Legrand

O’Connor-Von

. The effect of fenugreek on milk production and prolactin levels in mothers of preterm infants. Clin Lactat. 2013;4(4):159-165.

112.

Chelghoum

Khitri

Bouzid

Lakermi

. New trends in the use of medicinal plants by Algerian diabetic patients, considerations of herb–drug interactions. J Ethnopharmacol. 2021;274:113984.

113.

Jardan

Ahad

Raish

, et al. Effects of garden cress, fenugreek and black seed on the pharmacodynamics of metoprolol: an herb–drug interaction study in rats with hypertension. Pharm Biol. 2021;59(1):1088-1097.

114.

Alam

Bin Jardan

Raish

Al-Mohizea

Ahad

Al-Jenoobi

. Effect of Nigella sativa and fenugreek on the pharmacokinetics and pharmacodynamics of amlodipine in hypertensive rats. Curr Drug Metab. 2020;21(4):318-325.

115.

Amini

Payandeh

Sheikhhossein

, et al. The effects of fenugreek seed consumption on blood pressure: a systematic review and meta-analysis of randomized controlled trials. High Blood Press Cardiovasc Prev. 2023;30(7):123-133.

116.

Ahad

Raish

Bin Jardan

Alam

Al-Mohizea

Al-Jenoobi

. Potential pharmacodynamic and pharmacokinetic interactions of Nigella sativa and Trigonella foenum-graecum with losartan in L-NAME–induced hypertensive rats. Saudi J Biol Sci. 2020;27(10):2544-2550.

117.

Al-Mohizea

Ahad

El-Maghraby

, et al. Effects of Nigella sativa, Lepidium sativum and Trigonella foenum-graecum on sildenafil disposition in beagle dogs. Eur J Drug Metab Pharmacokinet. 2015;40(2):219-224.

118.

Al-Jenoobi

Ahad

Mahrous

Al-Mohizea

AlKharfy

Al-Suwayeh

. Effects of fenugreek, garden cress, and black seed on theophylline pharmacokinetics in beagle dogs. Pharm Biol. 2015;53(2):296-300.

119.

Alkharfy

Al-Jenoobi

Al-Mohizea

Ansari

Raish

Al-Suwayeh

. Effects of Lepidium sativum, Nigella sativa, and Trigonella foenum-graecum on phenytoin pharmacokinetics in beagle dogs. Phytother Res. 2013;27(12):1800-1804.

120.

Alkharfy

Jan

Alotaibi

, et al. Clopidogrel–herb interactions: a pharmacokinetic and pharmacodynamic assessment in a rat model. Curr Drug Metab. 2021;22(12):969-977.

121.

Lambert

Cormier

. Potential interaction between warfarin and boldo–fenugreek. Pharmacotherapy. 2001;21(4):509-512.

122.

Izzo

Di Carlo

Borrelli

Ernst

. Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction. Int J Cardiol. 2005;98(1):1-14.

123.

Doolabh

Finnegan

Pehlivan

Farrand

. Oral fenugreek seed consumption and serotonin syndrome. Aust N Z J Psychiatry. 2019;53(12):1225.

124.

Basist

Khan

Jan

Gaurav Khan

Parveen

Ahmad

. Metabolite profiling and nephroprotective potential of the Zea mays L. silk extract against diclofenac-induced nephrotoxicity in Wistar rats. ACS Omega. 2022;7(41):36519-36534.

125.

Wang

Zhao

. Corn silk (Zea mays L.), a source of natural antioxidants with α-amylase, α-glucosidase, advanced glycation and diabetic nephropathy inhibitory activities. Biomed Pharmacother. 2019;110:510-517.

126.

Wang

Xiao

Ruan

Liu

. Beneficial effects of corn silk on metabolic syndrome. Curr Pharm Des. 2017;23(34):5097-5103.

127.

Al-Oqail

Al-Sheddi

Farshori

, et al. Corn silk (Zea mays L.) induced apoptosis in human breast cancer (MCF-7) cells via the ROS-mediated mitochondrial pathway. Oxid Med Cell Longevity. 2019;2019:9789241.

128.

Gulati

Singh

Rasane

Kaur

Nanda

. Anti-cancerous effect of corn silk: a critical review on its mechanism of action and safety evaluation. 3 Biotech. 2023;13(7):246.

129.

Velazquez

DVO

Xavier

Batista

JEM

De Castro Chaves

. Zea mays L. extracts modify glomerular function and potassium urinary excretion in conscious rats. Phytomedicine. 2005;12(5):363-369.

130.

Hasanudin

Hashim

Mustafa

. Corn silk (Stigma maydis) in healthcare: a phytochemical and pharmacological review. Molecules. 2012;17(8):9697-9715.

131.

Gumaih

Alasbahy

Alharethi

Al-Asmari

Al-Khulaidi

AWA

. Antiurolithiasis activities of Zea mays extract and its mechanism as an antiurolithiasis remedy. Am J Clin Exp Urol. 2023;11(5):443-451.

132.

Singh

Inbaraj

Kaur

Rasane

Nanda

. Phytochemical analysis and characterization of corn silk (Zea mays, G5417). Agronomy. 2022;12(4):777.

133.

Fleming

. PDR for Herbal Medicines. 2nd ed . Medical Economics Company; 2000:224-225.

134.

Singh

Rasane

Nanda

Kaur

. Bioactive compounds of corn silk and their role in management of glycaemic response. J Food Sci Technol. 2023;60(6):1695-1710.

135.

Sheng

Chen

. Evaluation of antidiabetic potential of corn silk in high fat diet/streptozotocin–induced type 2 diabetes mice model. Endoc Metab Immune Disord Drug Targets. 2021;21(1):131-138.

136.

Dong

Zhao

Hao

Sun

Huo

Wang

. Integrated molecular biology and metabonomics approach to understand the mechanism underlying reduction of insulin resistance by corn silk decoction. J Ethnopharmacol. 2022;284:114756.

137.

George

Idu

. Corn silk aqueous extracts and intraocular pressure of systemic and non-systemic hypertensive subjects. Clin Exp Optomet. 2015;98(2):138-149.

138.

Lee

Huang

Hsiang

. Antihypertensive effects of corn silk extract and its novel bioactive constituent in spontaneously hypertensive rats: the involvement of angiotensin-converting enzyme inhibition. Molecules. 2019;24(10):1886.

139.

Shi

. Corn silk tea for hypertension: a systematic review and meta-analysis of randomized controlled trials. Evidence-Based Complementary Altern Med. 2019;2019:2915498.

140.

Brinker

. Herbal contraindications & drug interactions: Plus herbal adjuncts with medicines. 2nd ed. Eclectic Medical Publications; 2010:73.

141.

Tassew

Assefa

Zeleke

Ferede

. Prevalence and associated factors of herbal medicine use among patients living with chronic disease in Ethiopia: a systematic review and meta-analysis. Metab Open. 2024;21:100280.

142.

Agbabiaka

Wider

Watson

Goodman

. Concurrent use of prescription drugs and herbal medicinal products in older adults: a systematic review. Drugs Aging. 2017;34(12):891-905.

143.

Lippert

Renner

. Herb–drug interaction in inflammatory diseases: review of phytomedicine and herbal supplements. J Clin Med. 2022;11(6):1567.

144.

Assi

AlMoussawi

Boukhary

Nasser

Wattar

Akel

. Examination of herbal–drug interactions: implications for patient safety and healthcare practice in Lebanon: a cross-sectional study. Open Public Health J. 2024;17:e18749445336623.

145.

Magee

MPD

Schwartz

McArthur

Liu

Tarn

. Why patients fail to seek information on OTC product interactions with a direct-acting oral anticoagulant: perspectives on information-seeking. BMC Primary Care. 2025;26(1):47.

146.

Humadi

Hassan

Ahjel

. Herbal medicine between current practice and knowledge needs: a national cross-sectional survey in Iraq. Iraqi J Pharm Sci. 2024;33(4):208-218.

147.

Wang

Chen

, et al. A comprehensive review on pharmacokinetic mechanisms of herb–herb/drug interactions in Chinese herbal formula. Pharmacol Ther. 2024;264:108728.

148.

Fasinu

Bouic

Rosenkranz

. An overview of the evidence and mechanisms of herb–drug interactions. Front Pharmacol. 2012;3:69.

149.

Hacker

. The burden of chronic disease. Mayo Clin Proc Innov Quality Outc. 2024;8(1):112-119.

150.

Chhabra

Singh

Upadhyay

. A review on herbal drug interaction. Asian J Pharm Res Dev. 2020;8(1):94-99.

151.

Mangoni

Jackson

. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004;57(1):6-14.

152.

Chen

Sneed

Pan

, et al. Herb–drug interactions: mechanistic and clinical considerations. Curr Drug Metab. 2012;13(5):640-651.

153.

Gupta

Chang

Nammi

Bensoussan

Bilinski

Roufogalis

. Interactions between antidiabetic drugs and herbs: an overview of mechanisms of action and clinical implications. Diabetol Metab Syndr. 2017;9:59.

Potential Drug Herbal Interaction of the Commonly Used Medicinal Plants in the Management of Nephrolithiasis in Iraq: A Mini-Review

Abstract

Keywords

Introduction

Review Methodology

Evidence Synthesis

Adiantum capillus-veneris

Ammi visnaga

Petroselinum sativum

Senegalia Senegal (Acacia senegal)

Tribulus terrestris

Trigonella foenum-graecum

Zea mays (Corn Silk)

Clinical Implications of Herb–Drug Interactions

Conclusion

Footnotes

Acknowledgment

ORCID iD

Funding

Declaration of Conflicting Interests

References